Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALCAMIST: Albumin and Crystalloid Administration in Septic Shock
NCT05148286Phase 4Recruiting
- Sponsor
- Asan Medical Center
- Start
- Jan 2022
- Primary completion
- Sep 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of albumin (human) in septic shock, sponsored by Asan Medical Center. Started Jan 2022; status: recruiting.
02
Drugs
albumin (human)
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT05148286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05148286.